FogPharma: Funding, Investors & Team (Sep 2026)
FogPharma was founded by Greg Verdine, a leader in creating new drugs for previously untreatable targets. The company develops cell-penetrating mini proteins that can target diseases beyond traditional treatments. With a team of experts in cancer research and therapy, FogPharma is dedicated to creating innovative cancer treatments. The company receives financial backing from a diverse group of investors and has a strong support network of founders, employees, and patients working toward the goal of improving cancer care. FogPharma is committed to delivering groundbreaking medicines to patients and improving their quality of life.
FogPharma has raised $323M across 2 funding rounds on record, the most recent an undisclosed round of $145M announced in Mar 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
FogPharma Company Profile and Key Stats
Latest funding round on record: Mar 2024.
FogPharma Funding Rounds
FogPharma raised $178M in a Series D announced in Nov 2022.
1.3 years later, an undisclosed round of $145M was announced in Mar 2024.
FogPharma Founders and Leadership Team
Contact details for the FogPharma team: 1 of 1 has an email address on file.
Start 14-day free trial →FogPharma Funding Compared to Other Biotechnology Startups
FogPharma's latest round of $145M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like FogPharma in Biotechnology and Cambridge
Companies Similar to FogPharma
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
FogPharma Funding FAQs
What does FogPharma do?
FogPharma was founded by Greg Verdine, a leader in creating new drugs for previously untreatable targets. The company develops cell-penetrating mini proteins that can target diseases beyond traditional treatments. With a team of experts in cancer research and therapy, FogPharma is dedicated to creating innovative cancer treatments. The company receives financial backing from a diverse group of investors and has a strong support network of founders, employees, and patients working toward the goal of improving cancer care. FogPharma is committed to delivering groundbreaking medicines to patients and improving their quality of life.
How much funding has FogPharma raised?
FogPharma has raised $323M across 2 rounds on record. The most recent is an undisclosed round of $145M announced in Mar 2024.
When did FogPharma last raise funding?
FogPharma's most recent funding round on record is an undisclosed round of $145M, announced in Mar 2024.
Who founded FogPharma?
FundedIQ lists Weiqing Zhou (Founder) at FogPharma.
Where is FogPharma headquartered?
FogPharma is based in Cambridge, Massachusetts, United States.
How many employees does FogPharma have?
FogPharma is in the 101-250 employee band.
How does FogPharma's funding compare to other Biotechnology startups?
FogPharma's latest round of $145M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's FogPharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FogPharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.